TherapeuticsMD Inc (NASDAQ:TXMD) - Share price - Overview

Stock Report

TherapeuticsMD Inc TXMD

Last Price
$5.46

Day Change
-0.53|-8.85%

As of 20/02/2019
19:51:19 EST | USD
Minimum 15 Minutes Delay.

Last Close5.99
Day Range5.46 - 6.08
Mkt Cap1.30Bil
52-Wk Range3.51 - 7.66
Yield %-
ISINUS88338N1072
Volume5,105,928
P/E-10.50
P/S78.74
P/CF-11.99

Share Price

Financials
201520162017
More ...
Income Statement
Revenue20.1419.3616.78
Operating Income-85.19-90.25-77.63
Net Income-85.08-89.88-76.93
Basic EPS-0.49-0.46-0.37
Avg. Diluted Shares Outstanding173196206
Balance Sheet
Current Assets70.68139.41139.55
Non Current Assets3.053.063.68
Total Assets73.73142.47143.23
Current Liabilities10.6714.9813.32
Total Liabilities10.6714.9813.32
Total Equity63.06127.49129.91
Cash Flow
Operating Cash Flow-79.04-69.14-76.16
Capital Expenditure-0.58-1.24-0.83
Free Cash Flow-79.63-70.38-76.98

In millions, except "Basic EPS". Currency is USD.

Company Profile

TherapeuticsMD Inc is a women's health care company focused on creating and commercializing products targeted exclusively for women. It is engaged in pre-commercialization activities for advanced hormone therapy pharmaceutical product.

Sector

Healthcare

Industry

Drug Manufacturers - Major

Stock Style

Small-Blend

Fiscal Year Ends

December

Employees

173
Key Stats
More ...
Price/Earning TTM-11.52
Price/Book10.62
Price/Sales TTM86.44
Rev Growth (3 year avg)3.74
EPS Growth (3 year avg)-
Operating Margin % TTM-462.69
Net Margin % TTM-458.50
ROE TTM-59.77
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.